DeutschNewstral
Article
bizjournals.com on 2021-04-07 18:07
St. Louis biotech startup Arch Oncology names new CEO
Related news
- St. Louis biotech startup Arch Oncology expands C-suite with new hirebizjournals.com
- St. Louis biotech startup Arch Oncology raises $105M in Series C fundingbizjournals.com
- Following $105M raise, St. Louis biotech startup Arch Oncology adds 3 execs to C-suitebizjournals.com
- St. Louis startup Arch Oncology to partner with pharmaceutical giant Merck on lead drug candidatebizjournals.com
- St. Paul biotech startup IGF Oncology names new CEObizjournals.com
- Wisconsin company acquires Arizona biotech startup to boost oncology businessbizjournals.com
- Arch Angels take stake in Minneapolis biotech startupbizjournals.com
- Arch Venture, biotech alums raise $800M for manufacturing startupbizjournals.com
- St. Louis biotech startup makes acquisitionbizjournals.com
- St. Louis biotech startup relocates to Baltimorebizjournals.com
- St. Louis biotech startup snags $20M investmentbizjournals.com
- Bruker Corp. acquires St. Louis biotech startupbizjournals.com
- What's next for startup Arch Oncology and its cancer-fighting drug after raising $105Mbizjournals.com
- Arch Grant startup establishes North American HQ in St. Louisbizjournals.com
- St. Louis Arch Angels surpass $100M in startup investmentbizjournals.com
- BioGenerator investment lures North Carolina biotech startup to St. Louisbizjournals.com
- St. Louis biotech startup grows again by acquisitionbizjournals.com
- St. Louis biotech startup taps former MilliporeSigma executive as CEObizjournals.com
- St. Louis biotech startup makes acquisition, targets commercializationbizjournals.com
- St. Louis biotech startup selected for prestigious accelerator programbizjournals.com